Riskpilot← Back to searchSign inGet full accessMARLOTT AB
ABActiveOrg 5562015866Fyllerydsvägen 15All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 19790 employees
Revenue 2025
SEK 346K
+22% vs 2024
EBITDA margin
90.8%
+23% vs 2024
Equity ratio
76.4%
Financial strength
Net profit 2025
SEK 250K
+23% vs 2024
| Revenue | SEK 346K | +22% |
| EBITDA | SEK 314K | +23% |
| Net profit | SEK 250K | +23% |
| Total assets | SEK 484K | +0% |
| Equity | SEK 370K | +16% |
| Employees | 0 | — |
Legal name
MARLOTT AB
Org number
5562015866
Legal form
Aktiebolag
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
17 oktober 1979
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom läkemedelsutveckling och läkemedelsanvändning inkluderande biostatisk utvärdering av studie data, utveckling och utvärdering av studie design, granskning av dokumentation rörande läkemedels farmakokinetik, säkerhet och effektivitet, konsultverksamhet inom vin-, hotell- och restaurangverksamhet, jämte därmed förenlig verksamhet.
Address
Fyllerydsvägen 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 284 | 340 | 339 | 284 | 346 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 256 | 311 | 308 | 256 | 314 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 256 | 311 | 308 | 256 | 314 |
| Net financials | — | — | 1 | 1 | 1 |
| Profit before tax | 256 | 311 | 308 | 257 | 315 |
| Tax | −53 | −64 | −63 | −53 | −65 |
| Net profit | 203 | 247 | 245 | 204 | 250 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 504 | 617 | 480 | 482 | 484 |
| Equity | 334 | 361 | 356 | 320 | 370 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 170 | 256 | 124 | 162 | 114 |
| Total debt | 170 | 256 | 124 | 162 | 114 |
EBITDA margin
90.8%
This company
15.8%
Market median
+475% vs market
20212025
Equity ratio
76.4%
This company
38.2%
Market median
+100% vs market
20212025
Return on equity
67.6%
This company
18.4%
Market median
+267% vs market
20212025
Net profit margin
72.3%
This company
8.1%
Market median
+793% vs market
20212025
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20212025
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MARLOTT AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Erling Nils Bengtsson | Chairman | 0 companies |
| Jan Per Martin Bergstrand | Board of Directors | 0 companies |
| Frida Hanna Charlotta Bergstrand | Deputy Board Member | 0 companies |